Clinical Trials Browser

Prostatic Hyperplasia × TroVax × Genitourinary × Clear all

NCT01194960 2020-10-19

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Terminated

Prostatic Hyperplasia, Prostatic Neoplasms